Internet Connectz

ESMO 2025: Overall Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer

News Connectz

(UroToday.com) The 2025 European Society for Medical Oncology (ESMO) Annual Congress held in Berlin, Germany, was host to a prostate, penile, and testicular cancers proffered paper session. Dr. Neal Shore presented the overall survival (OS) results …

Source link

Post Views: 2
Donate

Related Articles
We will be happy to hear your thoughts

      Leave a reply

      Internet Connectz
      Logo
      Internet Connectz
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Shopping cart